Image of DNA Helix

DNA Sequencing is the process of reading nucleotide bases in a DNA molecule. Unlock the genome and answer biology’s most challenging questions with innovative and accessible sequencing solutions from Life Technologies.

For over 25 years, Life Technologies sequencers have contributed to significant scientific breakthroughs, including sequencing of the first human genome and the discovery of genes implicated in diseases like cystic fibrosis. Our ongoing innovation in sequencing technologies continues to drive new discoveries.

From whole genome sequencing to targeted sequencing of specific genomic regions, Life Technologies sequencing portfolio supports a wide range of throughput and research application needs for DNA sequencing.

Which platform is right for you?

Featured Sequencing Products

 

Whole Genome Sequencing

 

Whole Genome Sequencing

Whole Genome Sequencing

WGS entails sequencing the entire genome and comparing that to a reference genome in order to detect the full range of genetic variation such as SNPs, insertions, deletions, inversions, complex rearrangements, and copy number variation.

De Novo Sequencing

De Novo Sequencing

"From the beginning" or de novo sequencing is the method of building a reference genome. This is achieved by randomly fragmenting the target DNA, sequencing then assembling those individual fragments to build a draft or even finished genome.

 

Targeted Sequencing

   
Gene Sequencing

Targeted Sequencing

Sequencing individual genes, gene regions, or sets of genes is a common targeted sequencing approach used in cancer and inherited disease research to screen known or discover novel germline and/or somatic mutations in focused areas of the genome.

SNPs or Variants Validation

SNP Genotyping & Variant Detection by Sequencing

Accurate variant confirmation using orthogonal technology (independent chemistry) follows discovery of novel variants. Life Technologies offers the gold standard and a fast approach for labs to validate their discoveries.

Exome Sequencing

Exome Sequencing

Targeted sequencing of the exome employs enrichment strategies that target coding exons.  The exome encompasses approximately 1% of the genome, yet contains approximately 85% of disease-causing mutations. For genetic researchers trying to unravel the causes of over 6,800 rare diseases1, exome sequencing enables the identification of single-nucleotide variants (SNVs), small insertions or deletions (indels), and rare de novo mutations that explain the heritability of complex diseases2.

 

Microbial Identification

Microbial Sequencing

Sequencing the 16S rRNA gene is an accurate and reliable method for microbial identification.

HLA Sequencing

HLA Sequencing

High resolution sequence-based HLA typing enables robust allele identification and comprehensive ambiguity resolution using Group Specific Sequencing Primers (GSSPs).
Mitochondrial Sequencing

Mitochondrial Sequencing

Variants in the mitochondrial genome are known to play a role in a number of human diseases. Targeted sequencing can be used to detect mutations present only in some copies of the mitochondrial genome (heteroplasmic mutations). Mitochondrial sequencing is also an important application for human identification and population genetics studies.

Sanger sequencing reagent rewards
Sanger sequencing reagents & kits